A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A phase 3 trial testing SCTB35 in diffuse large B-cell lymphoma, now recruiting.
Overview
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma is a phase 3 interventional study registered as NCT07570823, led by Sinocelltech, and recruiting when checked on 2026-09-11. Official title: A Phase 3 Randomised, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Planned enrolment is 101 participants (estimated). The study started in 2026-06-04 and primary completion is expected in 2027-11. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialA Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Shares SCTB35, Sinocelltech and the tag ctgov-ingest.
- TrialA Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer
Shares Sinocelltech and the tag ctgov-ingest.
- TrialSCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
Shares Sinocelltech and the tag ctgov-ingest.
- TrialA Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Shares Sinocelltech and the tag ctgov-ingest.
- TrialA Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialStudy Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialAZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialA Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.